Informative prior used in multivariate analysis Model #2
| Variables | Gaussian prior distribution on log(OR), N(mu, sigma²) | Prior OR (95% CrI) |
| RTX versus other bDMARDs | N(1.04, 0.281) | 2.8 (1.0 to 8.0) |
| Median age (years) | N(−0.079, 0.0016) | 0.9 (0.85 to 1.0) |
| Gender | N(−0.757, 0.189) | 0.5 (0.2 to 1.1) |
| Cardiovascular disease | N(0.752, 0.191) | 2.1 (0.9 to 5.0) |
| Chronic lung disease | N(0.752, 0.191) | 2.1 (0.9 to 5.0) |
| Conventional synthetic DMARDs | N(−0.757, 0.191) | 0.5 (0.2 to 1.1) |
| Other immunosuppressive agents | N(0.64, 0.145) | 1.9 (0.9 to 4.0) |
| Other variables | N(0, 0.428) | 1.0 (0.05 to 20) |
bDMARD, biological disease-modifying antirheumatic drug; CrI, credibility interval; DMARD, disease-modifying antirheumatic drug; RTX, rituximab.